Vitamin E plus fruquintinib and tislelizumab in refractory microsatellite-stable metastatic colorectal cancer: interim results of the phase II VENTIF study (ESMO Asia 2026) - Oct 1, 2026 - Abstract #224eP; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Metastases • P2 data • Colorectal Cancer • Oncology • Solid Tumor
|
|
Dawei Li; Zhiyu Chen; Shengping Wang; Chenchen Wang; Xu Wang; Qingyang Sun; Yanxi Yao
|